Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afinitor with Paclitaxel and Carboplatin in Advanced LC-NEC
NCT01317615Phase 4Completed
- Sponsor
- Novartis
- Start
- Apr 2011
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in large cell neuroendocrine carcinoma of the lung (LCNEC), sponsored by Novartis. Started Apr 2011; status: completed.
02
Drugs
everolimus
03
Conditions
large cell neuroendocrine carcinoma of the lung (LCNEC)
Beyond the preview
Go deeper on NCT01317615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01317615.